Rare Variants in the Splicing Regulatory Elements of EXOC3L4 Are Associated with Brain Glucose Metabolism in Alzheimer's Disease

Overview

Journal BMC Med Genomics

Publisher Biomed Central

Specialty Genetics

Date 2018 Sep 27

PMID 30255815

Citations 6

Authors

Jason E Miller

Manu K Shivakumar

Younghee Lee

Seonggyun Han

Emrin Horgousluoglu

Shannon L Risacher

Andrew J Saykin

Kwangsik Nho

Dokyoon Kim

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) is one of the most common neurodegenerative diseases that causes problems related to brain function. To some extent it is understood on a molecular level how AD arises, however there are a lack of biomarkers that can be used for early diagnosis. Two popular methods to identify AD-related biomarkers use genetics and neuroimaging. Genes and neuroimaging phenotypes have provided some insights as to the potential for AD biomarkers. While the field of imaging-genomics has identified genetic features associated with structural and functional neuroimaging phenotypes, it remains unclear how variants that affect splicing could be important for understanding the genetic etiology of AD.

Methods: In this study, rare variants (minor allele frequency < 0.01) in splicing regulatory element (SRE) loci from whole genome sequencing (WGS) in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, were used to identify genes that are associated with global brain cortical glucose metabolism in AD measured by FDG PET-scans. Gene-based associated analyses of rare variants were performed using the program BioBin and the optimal Sequence Kernel Association Test (SKAT-O).

Results: The gene, EXOC3L4, was identified as significantly associated with global cortical glucose metabolism (FDR (false discovery rate) corrected p < 0.05) using SRE coding variants only. Three loci that may affect splicing within EXOC3L4 contribute to the association.

Conclusion: Based on sequence homology, EXOC3L4 is likely a part of the exocyst complex. Our results suggest the possibility that variants which affect proper splicing of EXOC3L4 via SREs may impact vesicle transport, giving rise to AD related phenotypes. Overall, by utilizing WGS and functional neuroimaging we have identified a gene significantly associated with an AD related endophenotype, potentially through a mechanism that involves splicing.

Citing Articles

A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives.

Li L, Yu X, Sheng C, Jiang X, Zhang Q, Han Y Transl Neurodegener. 2022; 11(1):42.

PMID: 36109823 PMC: 9476275. DOI: 10.1186/s40035-022-00315-z.

An association test of the spatial distribution of rare missense variants within protein structures identifies Alzheimer's disease-related patterns.

Jin B, Capra J, Benchek P, Wheeler N, Naj A, Hamilton-Nelson K Genome Res. 2022; 32(4):778-790.

PMID: 35210353 PMC: 8997344. DOI: 10.1101/gr.276069.121.

The plasma peptides of Alzheimer's disease.

Florentinus-Mefailoski A, Bowden P, Scheltens P, Killestein J, Teunissen C, Marshall J Clin Proteomics. 2021; 18(1):17.

PMID: 34182925 PMC: 8240224. DOI: 10.1186/s12014-021-09320-2.

Genetic mapping of metabolic traits in the blind Mexican cavefish reveals sex-dependent quantitative trait loci associated with cave adaptation.

Riddle M, Aspiras A, Damen F, McGaugh S, Tabin J, Tabin C BMC Ecol Evol. 2021; 21(1):94.

PMID: 34020589 PMC: 8139031. DOI: 10.1186/s12862-021-01823-8.

Precision and Personalized Medicine: How Genomic Approach Improves the Management of Cardiovascular and Neurodegenerative Disease.

Strianese O, Rizzo F, Ciccarelli M, Galasso G, DAgostino Y, Salvati A Genes (Basel). 2020; 11(7).

PMID: 32640513 PMC: 7397223. DOI: 10.3390/genes11070747.

References

Fujita P, Rhead B, Zweig A, Hinrichs A, Karolchik D, Cline M . The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 2010; 39(Database issue):D876-82. PMC: 3242726. DOI: 10.1093/nar/gkq963. View

Nho K, West J, Li H, Henschel R, Bharthur A, Tavares M . Comparison of Multi-Sample Variant Calling Methods for Whole Genome Sequencing. IEEE Int Conf Systems Biol. 2015; 2014:59-62. PMC: 4496949. DOI: 10.1109/ISB.2014.6990432. View

He B, Guo W . The exocyst complex in polarized exocytosis. Curr Opin Cell Biol. 2009; 21(4):537-42. PMC: 2725219. DOI: 10.1016/j.ceb.2009.04.007. View

Moore C, Wallace J, Frase A, Pendergrass S, Ritchie M . Using BioBin to explore rare variant population stratification. Pac Symp Biocomput. 2013; :332-43. PMC: 3638724. View

Kent W . BLAT--the BLAST-like alignment tool. Genome Res. 2002; 12(4):656-64. PMC: 187518. DOI: 10.1101/gr.229202. View

. 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 2015; 11(3):332-84. DOI: 10.1016/j.jalz.2015.02.003. View

Beach T . A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?. Neurol Ther. 2017; 6(Suppl 1):5-13. PMC: 5520818. DOI: 10.1007/s40120-017-0072-x. View

Saykin A, Shen L, Yao X, Kim S, Nho K, Risacher S . Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement. 2015; 11(7):792-814. PMC: 4510473. DOI: 10.1016/j.jalz.2015.05.009. View

Zare-Shahabadi A, Masliah E, Johnson G, Rezaei N . Autophagy in Alzheimer's disease. Rev Neurosci. 2015; 26(4):385-95. PMC: 5039008. DOI: 10.1515/revneuro-2014-0076. View

10.

Moreau K, Renna M, Rubinsztein D . Connections between SNAREs and autophagy. Trends Biochem Sci. 2013; 38(2):57-63. DOI: 10.1016/j.tibs.2012.11.004. View

11.

Bloom G . Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014; 71(4):505-8. DOI: 10.1001/jamaneurol.2013.5847. View

12.

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E . TREM2 variants in Alzheimer's disease. N Engl J Med. 2012; 368(2):117-27. PMC: 3631573. DOI: 10.1056/NEJMoa1211851. View

13.

Risacher S, Kim S, Nho K, Foroud T, Shen L, Petersen R . APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 2015; 11(12):1417-1429. PMC: 4637003. DOI: 10.1016/j.jalz.2015.03.003. View

14.

Nho K, Horgusluoglu E, Kim S, Risacher S, Kim D, Foroud T . Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease. BMC Med Genomics. 2016; 9 Suppl 1:30. PMC: 4989889. DOI: 10.1186/s12920-016-0190-9. View

15.

Park S, Jung Y, Kim Y, Lee-Kang J, Lee K . Glucose/oxygen deprivation and reperfusion upregulate SNAREs and complexin in organotypic hippocampal slice cultures. Neuropathology. 2008; 28(6):612-20. DOI: 10.1111/j.1440-1789.2008.00927.x. View

16.

Jagust W, Bandy D, Chen K, Foster N, Landau S, Mathis C . The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010; 6(3):221-9. PMC: 2920531. DOI: 10.1016/j.jalz.2010.03.003. View

17.

Moore C, Wallace J, Frase A, Pendergrass S, Ritchie M . BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge. BMC Med Genomics. 2013; 6 Suppl 2:S6. PMC: 3654874. DOI: 10.1186/1755-8794-6-S2-S6. View

18.

Choi Y, Sims G, Murphy S, Miller J, Chan A . Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012; 7(10):e46688. PMC: 3466303. DOI: 10.1371/journal.pone.0046688. View

19.

Basile A, Wallace J, Peissig P, McCarty C, Brilliant M, Ritchie M . KNOWLEDGE DRIVEN BINNING AND PHEWAS ANALYSIS IN MARSHFIELD PERSONALIZED MEDICINE RESEARCH PROJECT USING BIOBIN. Pac Symp Biocomput. 2016; 21:249-60. PMC: 4824557. View

20.

Tanzi R . The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012; 2(10). PMC: 3475404. DOI: 10.1101/cshperspect.a006296. View